Scarica l'app Stockscreener
12.87
0.47%
0.0719
Precedente Chiudi:
$12.80
Aprire:
$12.76
Volume 24 ore:
127.13K
Relative Volume:
0.36
Capitalizzazione di mercato:
$371.17M
Reddito:
$66.59M
Utile/perdita netta:
$-104.93M
Rapporto P/E:
-2.6004
EPS:
-4.95
Flusso di cassa netto:
$-96.48M
1 W Prestazione:
+1.98%
1M Prestazione:
-18.14%
6M Prestazione:
+66.36%
1 anno Prestazione:
+132.13%
Intervallo 1D:
$12.32
$13.05
Intervallo di 1 settimana:
$12.09
$13.98
Portata 52W:
$4.09
$17.15
Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile
Nome
Enanta Pharmaceuticals Inc
Settore
Industria
Telefono
617 607 0800
Indirizzo
4 KINGSBURY AVENUE, WATERTOWN, MA
Confronta ENTA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENTA
Enanta Pharmaceuticals Inc
|
12.86 | 369.44M | 66.59M | -104.93M | -96.48M | -4.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.00 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.41 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
816.53 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
363.01 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.15 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-14 | Iniziato | JP Morgan | Overweight |
| 2025-10-01 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-07-28 | Ripresa | H.C. Wainwright | Buy |
| 2023-08-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-08-08 | Downgrade | Jefferies | Buy → Hold |
| 2022-12-09 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-10-07 | Iniziato | Jefferies | Buy |
| 2021-09-09 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-01-29 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-11-24 | Iniziato | Evercore ISI | Underperform |
| 2020-08-28 | Ripresa | ROTH Capital | Buy |
| 2020-08-26 | Iniziato | Piper Sandler | Overweight |
| 2020-07-27 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-03-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-11-22 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-05-24 | Iniziato | Wolfe Research | Outperform |
| 2019-04-23 | Aggiornamento | Berenberg | Hold → Buy |
| 2018-12-13 | Iniziato | Berenberg | Hold |
| 2018-06-06 | Iniziato | ROTH Capital | Buy |
| 2018-02-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-01-02 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2017-11-21 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-07-11 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-04-28 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2016-02-09 | Reiterato | Barclays | Underweight |
| 2015-10-23 | Downgrade | Barclays | Equal Weight → Underweight |
| 2015-10-23 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
Mostra tutto
Enanta Pharmaceuticals Inc Borsa (ENTA) Ultime notizie
Sentiment Review: What are Enanta Pharmaceuticals Inc.’s technical support levelsDividend Hike & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Guidance Update: Why is SWKH stock going downSwing Trade & Verified Short-Term Plans - baoquankhu1.vn
Enanta Pharmaceuticals to Present at the Wells Fargo Securities 2013 Healthcare Conference - AOL.com
Why Enanta Pharmaceuticals Inc. stock appeals to analystsJobs Report & Free Long-Term Investment Growth Plans - bollywoodhelpline.com
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Technical Reactions to ENTA Trends in Macro Strategies - Stock Traders Daily
JPM26: Enanta outlines strategy to lead in RSV therapeutics - Yahoo Finance
Chipmakers Recap: Is Enanta Pharmaceuticals Inc stock affected by interest rate hikesPortfolio Update Report & Free Technical Pattern Based Buy Signals - Bộ Nội Vụ
Income Plays: What makes Enanta Pharmaceuticals Inc. stock attractive to growth fundsJuly 2025 Market Mood & Growth Focused Entry Point Reports - Bộ Nội Vụ
Downgrade Watch: Why is Enanta Pharmaceuticals Inc stock going upJuly 2025 Summary & Trade Opportunity Analysis - baoquankhu1.vn
Is Enanta Pharmaceuticals Inc. stock trading at a premium valuationJuly 2025 Trade Ideas & Reliable Trade Execution Plans - ulpravda.ru
Will Enanta Pharmaceuticals Inc. stock gain from strong economyAnalyst Downgrade & Safe Swing Trade Setups - Улправда
Enanta Pharmaceuticals, Inc.Common Stock (NQ: ENTA - FinancialContent
What makes Enanta Pharmaceuticals Inc. stock attractive to growth fundsTrade Execution Strategies & Our Experts Decode Market Noise for You - bollywoodhelpline.com
Enanta advances RSV and immunology pipeline with key milestones ahead By Investing.com - Investing.com Nigeria
Enanta Pharmaceuticals (NASDAQ:ENTA) Receives "Buy" Rating from HC Wainwright - MarketBeat
Enanta Pharma (ENTA) Receives Buy Rating, Price Target Maintained | ENTA Stock News - GuruFocus
Baird reiterates Outperform rating on Enanta Pharmaceuticals stock By Investing.com - Investing.com Canada
Will Enanta Pharmaceuticals Inc. stock benefit from automationQuarterly Portfolio Summary & Daily Oversold Bounce Ideas - Улправда
Is Enanta Pharmaceuticals Inc. stock a safe haven assetWeekly Trend Report & Weekly Stock Breakout Alerts - ulpravda.ru
What valuation multiples suggest for Enanta Pharmaceuticals Inc. stock2025 Breakouts & Breakdowns & Fast Moving Market Watchlists - Улправда
Is Enanta Pharmaceuticals Inc. stock a bargain at current levelsJuly 2025 Rallies & Risk Controlled Daily Plans - Улправда
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook - PharmiWeb.com
Enanta advances RSV and immunology pipeline with key milestones ahead - Investing.com
Trading the Move, Not the Narrative: (ENTA) Edition - Stock Traders Daily
Enanta Pharma (ENTA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - BioSpace
Enanta Pharmaceuticals Insider Ups Holding During Year - Yahoo Finance
Meme Stocks: Why Enanta Pharmaceuticals Inc 9EP stock benefits from AI revolution2025 Geopolitical Influence & Free Long-Term Investment Growth Plans - moha.gov.vn
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
ENTA SEC FilingsEnanta Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains? - Yahoo Finance
What hedge fund activity signals for Enanta Pharmaceuticals Inc. stock2025 Market Outlook & Daily Growth Stock Investment Tips - Улправда
How Enanta Pharmaceuticals Inc. stock performs in interest rate cycles2025 Geopolitical Influence & Technical Pattern Recognition Alerts - Улправда
Does Enanta Pharmaceuticals Inc. stock trade at a discount to peersMarket Movement Recap & Smart Allocation Stock Tips - Улправда
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Rate Hike: Will Enanta Pharmaceuticals Inc. stock see insider buyingTrade Performance Summary & Daily Profit Focused Stock Screening - Улправда
Will Enanta Pharmaceuticals Inc. (9EP) stock see insider accumulationTrade Risk Report & Long-Term Safe Investment Ideas - Улправда
What margin trends mean for Enanta Pharmaceuticals Inc. stockJuly 2025 Retail & Free Verified High Yield Trade Plans - Улправда
Why Enanta Pharmaceuticals Inc. stock is considered a top pickMarket Activity Summary & Precise Trade Entry Recommendations - Улправда
Will Enanta Pharmaceuticals Inc. stock benefit from upcoming earnings reportsRate Hike & Accurate Technical Buy Alerts - Bölüm Sonu Canavarı
Aug Breakouts: Will Enanta Pharmaceuticals Inc. (9EP) stock outperform Dow Jones2025 Market Sentiment & Weekly High Momentum Picks - Улправда
Is Enanta Pharmaceuticals Inc. stock a buy in volatile marketsJuly 2025 Retail & Low Drawdown Momentum Ideas - DonanımHaber
Will Enanta Pharmaceuticals Inc. stock see insider buyingMarket Trend Report & Fast Exit and Entry Strategy Plans - Улправда
(ENTA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Enanta Pharmaceuticals Inc Azioni (ENTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.31%
2.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):